Corvus Pharmaceuticals Inc (CRVS)
R&D Expenses
$15.96M
Quarterly · Period ending: · USD
CRVS R&D Expenses
Latest reported$15.96Mperiod ending
Latest reported$15.96Mperiod ending
CRVS Quarterly R&D Expenses ($41.46K → $15.96M)
Quarterly R&D Expenses
High-resolution chart · PNG
CRVS r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 15,964,000 | |
| 11,175,000 | |
| 9,939,000 | |
| 8,454,000 | |
| 7,873,000 | |
| 7,453,000 | |
| 5,974,000 | |
| 5,222,000 | |
| 4,114,000 | |
| 4,075,000 | |
| 3,999,000 | |
| 3,965,000 | |
| 3,968,000 | |
| 4,594,000 | |
| 4,080,000 | |
| 10,365,000 | |
| 4,923,000 | |
| 5,100,000 | |
| 4,788,000 | |
| 6,991,000 | |
| 9,106,000 | |
| 8,230,000 | |
| 7,191,000 | |
| 6,619,000 | |
| 7,857,000 | |
| 10,163,000 | |
| 8,920,000 | |
| 8,996,000 | |
| 10,640,000 | |
| 9,419,000 | |
| 8,394,000 | |
| 8,374,000 | |
| 9,715,000 | |
| 12,103,000 | |
| 9,688,000 | |
| 10,733,000 | |
| 12,386,000 | |
| 13,497,000 | |
| 9,131,000 | |
| 7,707,000 | |
| 7,119,000 | |
| 5,397,000 | |
| 4,909,000 | |
| 2,514,000 | |
| 2,005,000 | |
| 1,924,000 | |
| 41,455 |